science
Study Finds Whole-Blood NAD+ Levels Stable Across Age Groups
A study published in Nature used a validated measurement system to assess NAD+ concentrations in seven independent human cohorts. Researchers determined that whole-blood NAD+ levels do not decline with age and remain stable across lifestyle interventions. The findings challenge the premise that NAD+ levels fall with aging and question its use as an aging biomarker.
May 14, 5:15 PM·1m read1 source
ER
foxnews.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
A new study has found that whole-blood NAD+ levels do not decline with age, contradicting a widely held view in aging research. Researchers used a rigorously validated ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry system that accounts for real-world analytical variability.
They quantified NAD+ across seven independent human cohorts and reported that levels remain remarkably stable with age. The same measurements showed stability across various lifestyle interventions. Levels did change as expected in response to nicotinamide riboside supplementation.
The authors stated that the results challenge the utility of blood NAD+ levels as a biomarker of ageing or lifestyle factors. The study was published in Nature on May 14, 2026.
The research team emphasized the importance of their analytical approach after noting inconsistent findings in prior human blood studies. Previous work had proposed that NAD+ levels in blood and tissues decline with age, a claim often cited as rationale for supplementation.
" The new data showed no such age-related drop in whole blood.
NAD+ levels rose following nicotinamide riboside supplementation, consistent with established biochemical pathways. Individual-level data from a twin-pair supplementation study were not made public because of privacy rules under GDPR but can be requested subject to institutional approval.
All other data supporting the findings are included in the article and its source data files. The study lists multiple prior papers that had reported conflicting or supporting associations between NAD+ and age.
